Nuestros servicios
Para Profesionales de la Salud
Liposcale®
Revolucionando la estratificación del riesgo cardiovascular con un test avanzado de lipoproteínas
Más información
Ser líderes en el campo de la metabolómica por RMN, ofreciendo servicios de alta calidad y soluciones innovadoras para comprender y analizar los perfiles metabólicos con precisión y eficacia.
Nuestra visión es impulsar avances significativos en la investigación biomédica y la medicina personalizada proporcionando información valiosa para mejorar la salud humana y el bienestar global. Nos esforzamos por ser reconocidos como un socio de confianza y experto en metabolómica de RMN, contribuyendo al avance científico y proporcionando soluciones que tengan un impacto positivo en la sociedad.
Nuestro equipo tiene más de 100 publicaciones en destacadas revistas científicas de todo el mundo.
Abstract The development and persistence of symptoms following SARS-CoV-2 infection, known as Post-COVID-19 Condition (PCC) or “long COVID,” represents a …
Abstract Despite the well-established protective role of HDL-cholesterol against atherosclerotic cardiovascular disease (ASCVD), several studies have observed a higher incidence …
Abstract Metabolic syndrome (MS) and systemic lupus erythematosus (SLE) represent two pathophysiologically distinct chronic conditions associated with elevated cardiovascular risk. …
Abstract Objectives Cardiovascular risk excess in rheumatoid arthritis (RA) cannot be explained by traditional risk factors alone. Recent experimental data …
Abstract Lipoprotein(a) (Lp(a)) is a proatherogenic particle that is considered an important cardiovascular risk modifier due to its association with …
Abstract Background: Long COVID represents a significant health challenge, with 10–20% of patients with COVID-19 experiencing persistent multiorgan symptoms. The …
Abstract Individuals with severe obesity (SO) are at a high risk of developing cardiovascular disease, but traditional lipid parameters are …
Abstract Individuals with severe obesity (SO) are at a high risk of developing cardiovascular disease, but traditional lipid parameters are …
Abstract People with type 2 diabetes mellitus (T2DM) are at high risk of cardiovascular disease (CVD), which is often not …
Abstract Background and aim: Triglycerides (TG) are independent cardiovascular risk markers, yet TG-lowering therapies have failed to reduce major adverse …